Before joining NovaMedica within five years Ivan Daskal was responsible for legal support and control of compliance with the legislation in the Russian branch of Allergan where within the frameworks of the cross-functional tasks he developed and played the key role in implementing a number of significant local and regulatory acts of the company which referred to commercial and marketing activities, organized work aimed at struggle against counterfeit products circulation in the Russian market. Earlier Ivan headed legal function in the Diagnostic Department of Abbott Laboratories LLC (Russia), in Energomash JSC and Dirol Cadbury LLC.
Ivan graduated from the Yaroslav-the-Wise Novgorod State University, faculty of law.
NovaMedica team in the TOP 100 INFLUENTIAL PEOPLE IN THE PHARMACEUTICAL BUSINESS 2024
28 November 2024
05 November 2024
03 November 2024
Branches of Russian medical universities are planned to be opened in Kazakhstan
02 December 2024
AI and automation to drive “substantial progress” in pharmaceutical analytical testing
02 December 2024
Study proposes system to produce endotoxin-free recombinant proteins
29 November 2024
Most life sciences CEOs expect to grow their head counts over the next 3 years: KPMG survey
29 November 2024
By clicking “Send”, you consent to the processing of your personal data. For more information, see Privacy Policy